期刊文献+

冠状动脉钙化与血浆脂蛋白a的相关性研究 被引量:1

下载PDF
导出
摘要 目的脂蛋白a与冠状动脉钙化的相关性及其在临床中的应用价值。方法选取136例行冠脉造影检查患者,分为A组(PCI),B组(冠状动脉狭窄50%至70%之间),C组(冠状动脉狭窄50%以下),并根据脂蛋白a水平(300mg/L)每组分为2个亚组,测定冠状动脉钙化积分,并随访一年复查冠脉造影、钙化积分、脂蛋白a,进行统计比较分析。结果随访前后各组之间脂蛋白a、钙化积分均有差异(P〈0.05),A2、B2、C2组之间脂蛋白a和钙化积分正相关。随访前后亚组之间冠脉粥样硬化进展有差异(P〈0.05)。结论脂蛋白a较高的患者,冠状动脉钙化较严重,冠状动脉粥样硬化进展过程较快,支架内再狭窄发生率较高。 Objective The correlation between lipoprotein (a)and coronary artery calcification and its application in clinical value. Methods Select 136 patients with coronary angiography examination,divided into group A(PCI),group B(Coronary artery stenosis 50% to 70%) ,group C(Coronary artery stenosis less than 50%) ,And according to the level of LP (a) (300 rag/L) in each group was divided into two subgroups,determine coronary artery calcium score. Follow-up of one year, reexamine coronary angiograpby examina tion,coronary artery calcium score,lipoprotein (a), made statistical comparative analysis. Results Lipoprotein (a) and calcification scores were different between the each groups before and after one year(P〈0.05). Lipoprotein (a) and the calcification score are positively correlated in group A2,B2~C2o There were differences in the progression of coronary atherosclerosis between the subgroups before and after one year(P〈0. 05). Conclusion Lipoprotein (a)in patients with a high, severe coronary artery calcification and coronary atherosclerosis progress faster, with a greater incidence of stent restenosis.
作者 鲍骏 邹丽婷
出处 《检验医学》 CAS 2016年第B09期12-13,共2页 Laboratory Medicine
关键词 脂蛋白A 冠状动脉钙化 Lipoprotein (a) Coronary artery calcification
  • 相关文献

参考文献5

二级参考文献47

  • 1张斌,高鑫,李湘,高健.冠状动脉粥样硬化性心脏病患者氧化应激水平和血管内皮功能观察[J].上海医学,2006,29(10):687-691. 被引量:8
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5220
  • 3Ridker PM, Danielson E, Fonseea FA, et al. Rosuvastation to prevent vascular events in men and women with elevated C-reactive protein [J].N Eng J Med, 2008, 359 (21) : 2195-2207.
  • 4Liu K, Victora GD, Schwickert TA, et al.In vivo analysis of dendritic cell development and homeosxasis [J].Science, 2009,324 : 392-397.
  • 5Ridker PM, Danielson E, Fonseca FA, etal. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial [J].Lancet, 2009, 373 (9670) : 1175-1182.
  • 6Habib SS.Lipoprotein (a) The bad cholesterol [J].Saudi Med J, 2004,25 (4) : 429 -433.
  • 7Task Force on Myocardial Revascularization of the European Society of Cardiology,the European Association for Cardio-Thoracic Surgery,European Association for Percutaneous Cardiovascular Interventions,et al.Guidelines on myocardial revascularizafion.Eur J Cardiothorac Surg,2010,38:S1-S52.
  • 8HillisLD,SmithPK,AndersonJL,etal.2011ACCF/AHAGuideline for Coronary Artery Bypass Graft Surgery:executive summary:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation,2011,124:2610-2642.
  • 9Sianos G,Morel MA,Kappetein AP,et al.The Syntax Score:an angiographic tool grading the complexity of coronary artery disease.Eurolntervention,2005,1:219-227.
  • 10Rumberger JA,Simons DB,Fitzpatrick LA,et al.Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area.A histopathologic correlative study.Circulation,1995,92:2157-2162.

共引文献33

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部